Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
No current S&P 500 role.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
No current colleagues on record.
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2021 | MRNA | Sale | 5,000 | $237.00 | $1.2M |
| Jun 23, 2021 | MRNA | Sale | 5,000 | $219.65 | $1.1M |
| Jun 16, 2021 | MRNA | Sale | 5,000 | $200.00 | $1.0M |
| Jun 9, 2021 | MRNA | Sale | 5,000 | $212.30 | $1.1M |
| Jun 2, 2021 | MRNA | Sale | 5,000 | $183.90 | $920K |
| May 26, 2021 | MRNA | Sale | 5,000 | $168.70 | $844K |
| May 19, 2021 | MRNA | Sale | 5,000 | $155.74 | $779K |
| May 12, 2021 | MRNA | Sale | 5,000 | $154.11 | $771K |
| May 10, 2021 | MRNA | Sale | 100 | $161.64 | $16K |
| May 10, 2021 | MRNA | Sale | 200 | $159.63 | $32K |
| May 10, 2021 | MRNA | Sale | 1,585 | $158.88 | $252K |
| May 10, 2021 | MRNA | Sale | 985 | $157.48 | $155K |
| May 10, 2021 | MRNA | Sale | 600 | $156.60 | $94K |
| May 10, 2021 | MRNA | Sale | 200 | $163.12 | $33K |
| May 3, 2021 | MRNA | Sale | 1,924 | $187.10 | $360K |
| May 3, 2021 | MRNA | Sale | 916 | $188.00 | $172K |
| May 3, 2021 | MRNA | Sale | 1,089 | $186.04 | $203K |
| May 3, 2021 | MRNA | Sale | 800 | $184.77 | $148K |
| May 3, 2021 | MRNA | Sale | 271 | $183.42 | $50K |
| Apr 26, 2021 | MRNA | Sale | 900 | $177.41 | $160K |
| Apr 26, 2021 | MRNA | Sale | 400 | $175.03 | $70K |
| Apr 26, 2021 | MRNA | Sale | 551 | $175.97 | $97K |
| Apr 26, 2021 | MRNA | Sale | 200 | $173.03 | $35K |
| Apr 26, 2021 | MRNA | Sale | 1,829 | $178.51 | $326K |
| Apr 26, 2021 | MRNA | Sale | 100 | $179.37 | $18K |
| Apr 26, 2021 | MRNA | Sale | 580 | $169.87 | $99K |
| Apr 26, 2021 | MRNA | Sale | 439 | $171.05 | $75K |
| Apr 26, 2021 | MRNA | Sale | 1 | $171.65 | $172 |
| Apr 19, 2021 | MRNA | Sale | 100 | $167.56 | $17K |
| Apr 19, 2021 | MRNA | Sale | 700 | $166.31 | $116K |
| Apr 19, 2021 | MRNA | Sale | 462 | $165.04 | $76K |
| Apr 19, 2021 | MRNA | Sale | 1,250 | $162.65 | $203K |
| Apr 19, 2021 | MRNA | Sale | 500 | $163.89 | $82K |
| Apr 19, 2021 | MRNA | Sale | 656 | $160.48 | $105K |
| Apr 19, 2021 | MRNA | Sale | 1,332 | $161.62 | $215K |
| Apr 12, 2021 | MRNA | Sale | 1,400 | $138.06 | $193K |
| Apr 12, 2021 | MRNA | Sale | 413 | $140.22 | $58K |
| Apr 12, 2021 | MRNA | Sale | 400 | $141.79 | $57K |
| Apr 12, 2021 | MRNA | Sale | 100 | $143.09 | $14K |
| Apr 12, 2021 | MRNA | Sale | 863 | $137.16 | $118K |
| Apr 12, 2021 | MRNA | Sale | 1,824 | $139.38 | $254K |
| Apr 5, 2021 | MRNA | Sale | 2,426 | $129.96 | $315K |
| Apr 5, 2021 | MRNA | Sale | 1,150 | $130.95 | $151K |
| Apr 5, 2021 | MRNA | Sale | 610 | $127.76 | $78K |
| Apr 5, 2021 | MRNA | Sale | 814 | $128.65 | $105K |
| Mar 22, 2021 | MRNA | Sale | 255 | $142.83 | $36K |
| Mar 22, 2021 | MRNA | Sale | 290 | $146.46 | $42K |
| Mar 22, 2021 | MRNA | Sale | 227 | $145.47 | $33K |
| Mar 22, 2021 | MRNA | Sale | 61 | $147.50 | $9K |
| Mar 22, 2021 | MRNA | Sale | 366 | $144.06 | $53K |
| Mar 15, 2021 | MRNA | Sale | 602 | $138.26 | $83K |
| Mar 15, 2021 | MRNA | Sale | 300 | $139.09 | $42K |
| Mar 15, 2021 | MRNA | Sale | 1,874 | $140.38 | $263K |
| Mar 15, 2021 | MRNA | Sale | 2,988 | $141.31 | $422K |
| Mar 15, 2021 | MRNA | Sale | 2,101 | $142.17 | $299K |
| Mar 15, 2021 | MRNA | Sale | 957 | $143.09 | $137K |
| Mar 15, 2021 | MRNA | Sale | 801 | $137.00 | $110K |
| Mar 15, 2021 | MRNA | Sale | 411 | $136.00 | $56K |
| Mar 8, 2021 | MRNA | Sale | 1,547 | $123.48 | $191K |
| Mar 8, 2021 | MRNA | Sale | 273 | $124.35 | $34K |
| Mar 8, 2021 | MRNA | Sale | 1,361 | $125.68 | $171K |
| Mar 8, 2021 | MRNA | Sale | 1,350 | $126.75 | $171K |
| Mar 8, 2021 | MRNA | Sale | 1,855 | $127.73 | $237K |
| Mar 8, 2021 | MRNA | Sale | 2,312 | $129.80 | $300K |
| Mar 8, 2021 | MRNA | Sale | 2,611 | $130.76 | $341K |
| Mar 8, 2021 | MRNA | Sale | 2,000 | $131.83 | $264K |
| Mar 8, 2021 | MRNA | Sale | 471 | $132.91 | $63K |
| Mar 8, 2021 | MRNA | Sale | 2,698 | $128.62 | $347K |
| Mar 1, 2021 | MRNA | Sale | 450 | $157.29 | $71K |
| Mar 1, 2021 | MRNA | Sale | 2,201 | $146.68 | $323K |
| Mar 1, 2021 | MRNA | Sale | 1,986 | $147.71 | $293K |
| Mar 1, 2021 | MRNA | Sale | 700 | $149.00 | $104K |
| Mar 1, 2021 | MRNA | Sale | 1,039 | $149.79 | $156K |
| Mar 1, 2021 | MRNA | Sale | 600 | $150.86 | $91K |
| Mar 1, 2021 | MRNA | Sale | 900 | $152.01 | $137K |
| Mar 1, 2021 | MRNA | Sale | 753 | $154.34 | $116K |
| Mar 1, 2021 | MRNA | Sale | 600 | $155.69 | $93K |
| Mar 1, 2021 | MRNA | Sale | 771 | $156.49 | $121K |
| Feb 22, 2021 | MRNA | Sale | 100 | $160.38 | $16K |
| Feb 22, 2021 | MRNA | Sale | 263 | $159.32 | $42K |
| Feb 22, 2021 | MRNA | Sale | 800 | $162.47 | $130K |
| Feb 22, 2021 | MRNA | Sale | 1,100 | $163.57 | $180K |
| Feb 22, 2021 | MRNA | Sale | 300 | $164.60 | $49K |
| Feb 22, 2021 | MRNA | Sale | 1,000 | $165.95 | $166K |
| Feb 22, 2021 | MRNA | Sale | 700 | $166.82 | $117K |
| Feb 22, 2021 | MRNA | Sale | 356 | $168.00 | $60K |
| Feb 22, 2021 | MRNA | Sale | 281 | $168.90 | $47K |
| Feb 22, 2021 | MRNA | Sale | 100 | $169.81 | $17K |
| Feb 8, 2021 | MRNA | Sale | 100 | $178.20 | $18K |
| Feb 8, 2021 | MRNA | Sale | 566 | $185.82 | $105K |
| Feb 8, 2021 | MRNA | Sale | 1,404 | $185.03 | $260K |
| Feb 8, 2021 | MRNA | Sale | 800 | $186.84 | $149K |
| Feb 8, 2021 | MRNA | Sale | 300 | $179.43 | $54K |
| Feb 8, 2021 | MRNA | Sale | 100 | $180.74 | $18K |
| Feb 8, 2021 | MRNA | Sale | 400 | $182.92 | $73K |
| Feb 1, 2021 | MRNA | Sale | 100 | $174.00 | $17K |
| Feb 1, 2021 | MRNA | Sale | 700 | $172.86 | $121K |
| Feb 1, 2021 | MRNA | Sale | 100 | $171.30 | $17K |
| Feb 1, 2021 | MRNA | Sale | 200 | $165.32 | $33K |
| Feb 1, 2021 | MRNA | Sale | 600 | $164.20 | $99K |
SEC reporting-owner ID (CIK) 1690927 · all filings on EDGAR